AI-crafted universal coronavirus vaccine clears first-in-human trial
TL;DR
Cambridge researchers and DIOSynVax report the first-in-human trial of an AI-designed 'super-antigen' universal coronavirus vaccine. The DNA vaccine, created entirely by computer simulations and delivered via a needle-free micro‑jet system, was safe in 39 volunteers and elicited immune responses against SARS-CoV-2, SARS, and related bat coronaviruses, suggesting broad protection beyond current strains. A Phase 2 study is planned to confirm wider protection, with the approach potentially adaptable to other virus families.
- AI-designed universal coronavirus vaccine passes first human trial ScienceDaily
- 'World-first' vaccine designed by artificial intelligence BBC
- First AI-designed 'universal vaccine' tested in humans: UK researchers Medical Xpress
- New ‘universal vaccine’ technology could protect us from future virus outbreaks University of Cambridge
- AI ‘super-antigen’ vaccine could protect against whole families of viruses The Independent
Want the full story? Read the original reporting
Read on ScienceDaily